Taro Pharmaceutical
TARO
$23.30
Share price
1.30%
Change (1 day)
-46.34%
Change (1 year)
EPS for Taro Pharmaceutical (TARO)
EPS in 2022 (TTM): $1.73
According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.73. In 2021 the company made an earnings per share (EPS) of $0.04000 an increase over its 2020 EPS that were of -$7.91.
EPS history for Taro Pharmaceutical from 2011 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | $1.73 | 4225% |
| 2021 | $0.04000 | -100.51% |
| 2020 | -$7.91 | -222.45% |
| 2019 | $6.46 | -18.02% |
| 2018 | $7.88 | 53.01% |
| 2017 | $5.15 | -55.95% |
| 2016 | $11.69 | -13.41% |
| 2015 | $13.50 | 36.92% |
| 2014 | $9.86 | 37.71% |
| 2013 | $7.16 | 21.15% |
| 2012 | $5.91 | 44.15% |
| 2011 | $4.10 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $6.83 | 294.77% | 🇺🇸 USA |
 Novartis NVS | $3.19 | 84.39% | 🇨🇭 Switzerland |
 Pfizer PFE | $5.60 | 223.70% | 🇺🇸 USA |
 Merck MRK | $5.73 | 231.21% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.91 | 357.03% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.12 | -222.54% | 🇮🇱 Israel |